Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games, and Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, announce the signing of a definitive merger agreement to form a diversified, leading digital health company. Under the terms of the agreement, Akili shareholders will receive $0.4340 per share of common stock in cash. The per share purchase price represents an approximately 4% premium to Akili’s closing stock price on May 28, 2024 and an approximately 85% premium to Akili’s closing price on April 29, 2024, the last trading day prior to Akili’s public announcement that it was evaluating potential strategic alternatives.
Read the full article: Virtual Therapeutics, Akili Interactive Enter into Definitive Merger Agreement to Establish Leading Digital Health Company //
Source: https://www.businesswire.com/news/home/20240529504802/en/Virtual-Therapeutics-Akili-Interactive-Enter-Into-Definitive-Merger-Agreement-to-Establish-Leading-Digital-Health-Company